Biohaven | BiotechTV

top of page

Jun 6

Biohaven's CEO recaps last week's R&D Day and walks us through the company's pipeline

From the NYSE, Vlad Coric covers programs including protein degradation, ADCs, myostatin inhibition, the ion channel programs, and...

Vlad Coric talks about the pipeline 'New Biohaven' has in motion after Pfizer's acquisition of its CGRPs

Jan 7

Company News

Vlad Coric talks about the pipeline 'New Biohaven' has in motion after Pfizer's acquisition of its CGRPs

He discusses protein degradation, KV7 ion channel modulation, myostatin inhibition for obesity, and more.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh